HUMANA INC
$461.25
+17.57 (+3.96%) · delayed · Nov 16, 2026
Five-year price
52w $163.11 to $462.87
- Market cap
- $55.4B
- Enterprise value
- $63.6B
- P/E
- 46.9×
- 34.8× on 3y avg EPS
- EV / EBIT
- 23.5×
- FCF yield
- 0.7%
- ROIC
- 8.6%
- Debt / equity
- 0.70
- Piotroski F
- 5/9
Value scorecard · FY2025
Does it pass the value tests?
Quality
- ○ROIC > 12% (5y avg)5y avg ROIC 10.7%
- ○ROE > 15% (5y avg)5y avg ROE 13.2%
- ●Stable operating marginsMargin volatility 0.9% (σ, 5y)
- ●Earnings convert to cashFCF / net income 101% (5y avg)
- ●Growing revenueRevenue CAGR 5y 10.9%
- ●Shrinking share countDiluted shares -9.2% over 5y
Value
- ○P/E below 15P/E 46.9
- ○EV/EBIT below 12EV/EBIT 23.5
- ○FCF yield above 6%FCF yield 0.7%
- ○Price below Graham NumberGraham Number $180.41
- ○P/B below 3P/B 3.1
Safety
- ○Debt / equity below 0.5D/E 0.70
- ○Debt payable in < 4 yrs of earningsNet debt $8.2B
- ○Interest coverage > 8xCoverage 4.3x
- ●Current ratio > 1.5Current ratio 2.00
- ○Piotroski F-score ≥ 6F-score 5/9
Graham Defensive
- ●Adequate size (revenue > $2B)Revenue $129.7B
- ●Strong condition (current ratio ≥ 2)Current ratio 2.00
- ●Earnings stability (no loss, 10y)10 years of data
- ●Uninterrupted dividendsDividends paid every year on record
- ○Earnings growth ≥ 33% (10y, 3y avgs)EPS growth 21%
- ○Moderate P/E (≤ 15 on 3y avg EPS)P/E (3y avg) 34.8
- ○P/E × P/B ≤ 22.5Product 109.0
Valuation lab
What do you have to believe?
At $461.25, the market is pricing in about 34.7% annual free-cash-flow growth for the next decade (9% discount rate, 2.5% terminal growth).
Starting cash flow
Net debt $8.2B · 120M shares · 5y revenue CAGR 10.9%
Intrinsic value
$25.59
Price
$461.25
Premium paid
1702%
What the price implies
The market is paying for 34.7% annual cash-flow growth for 10 years at a 9.0% discount rate.
Terminal value share
63% of the value sits beyond year 10.
Financial statements
A decade of the record.
USD millions · fiscal years · source: SEC 10-K XBRL
| Line item | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 54,379 | 53,767 | 56,912 | 64,888 | 77,155 | 83,064 | 92,870 | 106,374 | 117,761 | 129,664 |
| Gross profit | — | — | — | — | — | — | — | — | — | — |
| Operating income | 1,741 | 4,262 | 3,100 | 3,192 | 4,986 | 3,148 | 3,800 | 4,013 | 2,562 | 2,704 |
| Operating margin | 3.2% | 7.9% | 5.4% | 4.9% | 6.5% | 3.8% | 4.1% | 3.8% | 2.2% | 2.1% |
| Pre-tax income | 1,552 | 4,020 | 2,074 | 3,470 | 4,674 | 3,419 | 3,564 | 3,325 | 1,620 | 1,438 |
| Income tax | 938 | 1,572 | 391 | 763 | 1,307 | 485 | 762 | 836 | 413 | 250 |
| Net income | 614 | 2,448 | 1,683 | 2,707 | 3,367 | 2,933 | 2,806 | 2,489 | 1,207 | 1,188 |
| EPS (diluted) | 4.07 | 16.81 | 12.16 | 20.10 | 25.31 | 22.67 | 22.08 | 20.00 | 9.98 | 9.84 |
| Diluted shares | 151 | 146 | 138 | 135 | 133 | 129 | 127 | 124 | 121 | 121 |
Who owns it